Amlodipine Besylate; Telmisartan Patent Expiration
Amlodipine Besylate; Telmisartan is Used for managing high blood pressure. It was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Amlodipine Besylate; Telmisartan Patents
Given below is the list of patents protecting Amlodipine Besylate; Telmisartan, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Twynsta | US5591762 | Benzimidazoles useful as angiotensin-11 antagonists |
Jan 07, 2014
(Expired) | Boehringer Ingelheim |
Amlodipine Besylate; Telmisartan's Family Patents

Explore Our Curated Drug Screens
Amlodipine Besylate; Telmisartan Generic API Manufacturers
Several generic applications have been filed for Amlodipine Besylate; Telmisartan. The first generic version for Amlodipine Besylate; Telmisartan was by Lupin Ltd and was approved on Jan 8, 2014. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Nov 17, 2016.
Given below is the list of companies who have filed for Amlodipine Besylate; Telmisartan generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Telmisartan. All of these versions come by the name TELMISARTAN AND AMLODIPINE. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE; 40MG | tablet | Discontinued | ORAL | N/A | Nov 17, 2016 |
EQ 10MG BASE; 40MG | tablet | Discontinued | ORAL | N/A | Nov 17, 2016 |
EQ 5MG BASE; 80MG | tablet | Discontinued | ORAL | N/A | Nov 17, 2016 |
EQ 10MG BASE; 80MG | tablet | Discontinued | ORAL | N/A | Nov 17, 2016 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
2. LUPIN LTD
Lupin Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Telmisartan. All of these versions come by the name TELMISARTAN AND AMLODIPINE. Given below are the details of the strengths of this generic introduced by Lupin Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE; 40MG | tablet | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 10MG BASE; 40MG | tablet | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 10MG BASE; 80MG | tablet | Prescription | ORAL | AB | Jan 8, 2014 |
EQ 5MG BASE; 80MG | tablet | Prescription | ORAL | AB | Jan 8, 2014 |
Manufacturing Plant Locations New
Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
India |
|
3. MYLAN
Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Amlodipine Besylate; Telmisartan. All of these versions come by the name TELMISARTAN AND AMLODIPINE. Given below are the details of the strengths of this generic introduced by Mylan.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE; 80MG | tablet | Prescription | ORAL | AB | Aug 26, 2014 |
EQ 5MG BASE; 40MG | tablet | Prescription | ORAL | AB | Aug 26, 2014 |
EQ 10MG BASE; 40MG | tablet | Prescription | ORAL | AB | Aug 26, 2014 |
EQ 10MG BASE; 80MG
(reference standard) | tablet | Prescription | ORAL | AB | Aug 26, 2014 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
Country | City | Firm Name | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||||||||||
India |
| |||||||||||||||||
Canada |
| |||||||||||||||||
Ireland |
|
4. TORRENT
Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Amlodipine Besylate; Telmisartan. All of these versions come by the name TELMISARTAN AND AMLODIPINE. Given below are the details of the strengths of this generic introduced by Torrent.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE; 40MG | tablet | Discontinued | ORAL | N/A | Jan 8, 2014 |
EQ 10MG BASE; 40MG | tablet | Discontinued | ORAL | N/A | Jan 8, 2014 |
EQ 5MG BASE; 80MG | tablet | Discontinued | ORAL | N/A | Jan 8, 2014 |
EQ 10MG BASE; 80MG | tablet | Discontinued | ORAL | N/A | Jan 8, 2014 |
Manufacturing Plant Locations New
Torrent's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Torrent as present at those locations.
Country | City | Firm Name | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
| |||||||||||
United States |
|